![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | H01J 49/26 | |
G01T 1/38 | |||
G01N 24/00 | |||
C12Q 1/37 | |||
G01N 33/574 | |||
G01N 33/68 |
(11) | Patento numeris | 2805346 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 13735986.5 |
Europos patento paraiškos padavimo data | 2013-01-10 | |
(97) | Europos patento paraiškos paskelbimo data | 2014-11-26 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2018-05-30 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2013/021074 |
Data | 2013-01-10 |
(87) | Numeris | WO 2013/106603 |
Data | 2013-07-18 |
(30) | Numeris | Data | Šalis |
201261585202 P | 2012-01-10 | US |
(72) |
KRIZMAN, David, B., US
HEMBROUGH, Todd, US
THYPARAMBIL, Sheeno, US
LIAO, Wei-Liao, US
|
(73) |
Expression Pathology, Inc.,
9600 Medical Center Drive, Suite 300, Rockville, MD 20850,
US
|
(54) | SRM/MRM ASSAY FOR THE INSULIN RECEPTOR PROTEIN |
SRM/MRM ASSAY FOR THE INSULIN RECEPTOR PROTEIN |